Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ELITechGroup SAS
With the aging of the population, heart failure has emerged as a key public health concern. Several device-based technologies are poised to positively impact both ends of the disease spectrum, enabling earlier diagnosis and treatment, and providing more treatment options for those in later stages of the disease.
In Vivo presents another installment of our quarterly review of dealmaking--in this case April 2001-June 2001. Our data comes from Windhover's Strategic Transactions Database. We include medical device financings by industry segment and by deal type; medical device M&A; diagnostic financings and alliances by product category; pharma and biotech alliances by technology segment; pharma and biotech alliances by deal type, and pharma and biotech financings by market segment and therapeutic category.
- Other Names / Subsidiaries
- Amplimedical S.p.A.
- ELITechGroup Clinical Systems SAS
- ELITechGroup Biomedical Systems
- ELITechGroup B.V.
- ELITech Italia
- ELITech Latin America
- ELITech Microbio
- Epoch Biosciences